Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_assertion type Assertion NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_head.
- NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_assertion description "[We examined the effects of the mammalian target of rapamycin inhibitor, rapamycin, on mammary tumorigenesis in transgenic mice bearing an activated ErbB2 (NeuYD) transgene in the absence or presence of a second transgene encoding vascular endothelial growth factor (VEGF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_provenance.
- NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_assertion evidence source_evidence_literature NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_provenance.
- NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_assertion SIO_000772 15958580 NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_provenance.
- NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_assertion wasDerivedFrom befree-20140225 NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_provenance.
- NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_assertion wasGeneratedBy ECO_0000203 NP789189.RAWLzz4vyQY5Uh77aL1Tq7XOSeFEbsvzubaPBQnMpyh7g130_provenance.